360 NEWS360 NEWS

Healthcare · National

Sellas’ cancer vaccine extends survival in blood cancer trial, company says

The ⁠vaccine, called galinpepimut-S ⁠or GPS, was tested in patients with acute ​myeloid ‌leukaemia, a fast-growing cancer of the blood and bone marrow

Verified Timeline

No verified timeline updates.

Voluntary Reader Opinion

What is your view on “Sellas’ cancer vaccine extends survival in blood cancer trial, company says”?

This is self-selected reader participation, not representative scientific polling.